IperionX

IperionX staged a strong single-day uptrend, closing at $30.420, up 5.2%, driven by two key catalysts: a DoD award of up to $6.6 million for titanium plate production, and analyst Neal Dingmann raising the price target from $42 to $57, citing strengthening defense titanium demand and DoD program upside, alongside the company's recent deal to acquire rare earth and critical mineral assets adjacent to its Titan Project. While the intraday high of $30.590 represents a 40.44% rebound from the 52-week low of $21.66, the stock remains below both its 20-day MA ($31.985) and 60-day MA ($34.391), with a YTD decline of 23.78%. However, the company continues to operate at a loss—reporting a per-share loss of $0.50 for two consecutive quarters and a net loss widening 114% YoY—with a negative P/E ratio and high price-to-book of 9.54x, indicating the market is pricing in strategic optionality rather than current fundamentals.